Life Biosciences LLC
Epigenetic restoration therapy platform for cellular rejuvenation to reverse aging diseases
- Sector
- Biotech
- Headquarters
- BOSTON, MA
- Founded
- 2017
- Latest Form D
- $31M, Apr 2026
- Total capital
- $54M
- Grants
- —
- No SBIR or STTR on record
- Sector median 1 award
- Raised
- $54M
- 4 Form D · Apr 2026
- 6 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median 2 patents
Capital Timeline
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $31,000,002 | |
| Private capital raised | Form D · SEC | $18,185,552 | |
| Private capital raised | Form D · SEC | $5,149,996 |
1 record has no date or no amount, so it isn’t placed on the timeline.
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3385 | AGEX THERAPEUTICS INC | — | $19M |
| 3386 | Ultragenyx Pharmaceutical Inc. | — | $109M |
| 3387 | BlueSphere Bio, Inc. | — | $56M |
| 3388 | Life Biosciences LLC | — | $54M |
| 3389 | PhaseBio Pharmaceuticals Inc | — | $64M |
| 3390 | OPUS GENETICS INC. | — | $47M |
| 3391 | CERo Therapeutics, Inc. | — | $45M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Bracken DarrellDirector
- Alexander EdwardsExecutive Officer · Promoter
- Stuart GibsonDirector
- David GuyerDirector
- Mehmood KhanDirector · Executive Officer
- Brian MaloneExecutive Officer
- Gerald McLaughlinDirector · Executive Officer
- Adam NeumannDirector
Show all 14 people
- Michael RingelExecutive Officer
- Sharon Rosenzweig-LipsonExecutive Officer
- Amit ShashankExecutive Officer
- David SinclairDirector · Promoter
- Ilan SternDirector
- Nicholas VentrescaExecutive Officer
Patents
No patents are on record under this company's name.
USPTO publishes applications about 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won't match.
Checked: USPTO granted patents and published applications
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.